Phase 3 Mesothelioma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Unresectable Pleural Mesothelioma
AstraZeneca825 enrolled178 locationsNCT06097728
Recruiting
Phase 3
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Mesotheliomas Pleural
Gruppo Oncologico Italiano di Ricerca Clinica162 enrolled19 locationsNCT04996017
Active
Phase 3
DREAM3R: A phase 3 trial of durvalumab with chemotherapy as first line treatment in mesothelioma
Pleural Mesothelioma (PM)
University of Sydney480 enrolled34 locationsACTRN12620001199909
Terminated
Phase 3
Opioids for breathlessness in people with mesothelioma or asbestosis or other causes of interstitial lung disease.
Dyspnoea in opioid naive participants with mesothelioma or asbestosis or other causes of interstitial lung disease.
Flinders University - Department of Palliative and Support Services144 enrolled3 locationsACTRN12611000711910
Completed
Phase 3
MATES: Maintenance Thalidomide in Mesothelioma Patients. A phase III trial of anti-angiogenic agent Thalidomide in patients with malignant pleural mesothelioma after first line chemotherapy.
Unresectable malignant mesothelioma
University of Sydney100 enrolled1 locationACTRN12609000141246